GARRITY THOMAS J 4
4 · ANTARES PHARMA, INC. · Filed Jan 13, 2021
Insider Transaction Report
Form 4
GARRITY THOMAS J
Director
Transactions
- Sale
Common Stock
2021-01-11$4.07/sh−20,000$81,400→ 224,406 total - Exercise/Conversion
Common Stock
2021-01-11$1.12/sh+50,000$56,000→ 274,406 total - Sale
Common Stock
2021-01-11$4.05/sh−50,000$202,500→ 224,406 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-11−20,000→ 0 totalExercise: $2.24Exp: 2021-09-09→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2021-01-11$2.24/sh+20,000$44,800→ 244,406 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-11−50,000→ 0 totalExercise: $1.12Exp: 2026-06-02→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested and became exercisable in four equal quarterly installments from the grant date of September 9, 2011.
- [F3]The options vested and became exercisable in four equal quarterly installments from the grant date of June 2, 2016.